| Main Title |
Some pharmaceutical drugs. |
| CORP Author |
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. |
| Publisher |
World Health Organization, International Agency for Research on Cancer, |
| Year Published |
1996 |
| OCLC Number |
36261849 |
| ISBN |
9283212665; 9789283212669 |
| Subjects |
Drugs--Physiological effect--Congresses ;
Carcinogens--Congresses ;
Geneesmiddelen ;
Carcinogeniteit ;
Benzodiazepines--toxicity ;
Estrogen Antagonists--toxicity ;
Hypolipidemic Agents--toxicity ;
Neoplasms--chemically induced ;
Antilipemic Agents--toxicity
|
| Internet Access |
|
| Holdings |
| Library |
Call Number |
Additional Info |
Location |
Last
Modified |
Checkout
Status |
| EJDM |
RC268.57.I26 v.66 1996 |
|
Env Science Center Library/Ft Meade,MD |
01/30/1998 |
| EKBD |
IARC/MON-66 |
|
Research Triangle Park Library/RTP, NC |
03/14/1997 |
|
| Collation |
iv, 514 pages : illustrations ; 25 cm. |
| Notes |
"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans which met in Lyon, 13-20 February 1996." Includes bibliographical references and index. |
| Contents Notes |
Preamble -- General remarks -- The mongraphs: Benzodiazepines and related compunds and phenytoin: Diazepam. Doxefazepam. Estazolam. Oxazepam. Prazepam. Ripazepam. Temazepam. Phenytoin ; Anti-oestrogenic compounds: Droloxifene. Tamoxifen. Toremifene ; Hypolipidaemic drugs: Clofibrate. Gemfibrozil -- Summary of final evaluations -- Glossary -- Appendix 1. Summary tables of genetic and related effects -- Appendix 2. Activity profiles for genetic and related effects. |
